BioTech 365

APRIL 2, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck KGaA lands rights to 3rd F-star oncology bispecific antibody.Merck KGaA lands rights to 3rd F-star oncology bispecific antibody ntaylor Fri, 04/02/2021 – 06:13 from FierceBiotech: Biotech … Continue reading → (..)

Antibody 40

Antibody Research 40

BioTech 365

APRIL 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Epizyme’s EZH2 blocker boosts immuno-oncology response in prostate cancer models.Epizyme’s EZH2 blocker boosts immuno-oncology response in prostate cancer models arlene.weintraub Mon, 04/19/2021 – 09:02 from FierceBiotech: (..)

Research 40

Research 40

BioTech 365

NOVEMBER 9, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Attacking pancreatic cancer with a novel immuno-oncology drug conjugate.Attacking pancreatic cancer with a novel immuno-oncology drug conjugate arlene.weintraub Mon, 11/09/2020 – 08:09 from FierceBiotech: Biotech [link]. (..)

Drugs 40

Drugs Research 40

BioTech 365

FEBRUARY 11, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Glioblastoma map points to new protein targets and immuno-oncology approaches.Glioblastoma map points to new protein targets and immuno-oncology approaches arlene.weintraub Thu, 02/11/2021 – 10:28 from FierceBiotech: Biotech (..)

Protein 40

Protein Research 40

BioTech 365

APRIL 23, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Replimune, prepping for market, taps Genentech oncology vet as CMO.Chutes & Ladders—Replimune, prepping for market, taps Genentech oncology vet as CMO fkansteiner Thu, 04/22/2021 – … Continue (..)

Marketing 40

Marketing Research 40

BioTech 365

NOVEMBER 1, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MIT team uncovers differences in T cells that drive immuno-oncology resistance in lung cancer.MIT team uncovers differences in T cells that drive immuno-oncology resistance in lung cancer … Continue reading →

Research 40

Research 40

BioTech 365

OCTOBER 19, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Injured tumor cells activate immuno-oncology drugs to combat breast cancer and melanoma in mice.Injured tumor cells activate immuno-oncology drugs to combat breast cancer and melanoma in mice … Continue reading →

Drugs 40

Drugs Research 40

BioTech 365

JUNE 10, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Old antidepressants show promise as immuno-oncology treatments in melanoma and colon cancer.Old antidepressants show promise as immuno-oncology treatments in melanoma and colon cancer arlene.weintraub Wed, 06/09/2021 – … (..)

Research 40

Research 40

BioTech 365

JANUARY 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scorpion Therapeutics strikes major $162M funding round for ‘precision oncology 2.0’ ’ Scorpion Therapeutics strikes major $162M funding round for ‘precision oncology 2.0’

Research 40

Research 40

BioTech 365

DECEMBER 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix for its pipeline of T-cell engagers.Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix for its … Continue reading → (..)

Research 40

Research 40

BioTech 365

FEBRUARY 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Boosting the response to immuno-oncology in pancreatic cancer by targeting inflammation.Boosting the response to immuno-oncology in pancreatic cancer by targeting inflammation arlene.weintraub Mon, 02/08/2021 – 09:45 from (..)

Research 40

Research 40

BioTech 365

SEPTEMBER 18, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Olema Oncology brings on AstraZeneca vet Bohen as CEO.Chutes & Ladders—Olema Oncology brings on AstraZeneca vet Bohen as CEO kblankenship Thu, 09/17/2020 – 14:40 from … Continue reading → (..)

Research 40

Research 40

BioTech 365

JUNE 7, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ASCO: Alpine reports 61% ‘clinical benefit’ in early trial of CD28-targeted immuno-oncology drug.ASCO: Alpine reports 61% ‘clinical benefit’ in early trial of CD28-targeted immuno-oncology drug arlene.weintraub (..)

Trials 40

Trials Drugs Research 40

BioTech 365

DECEMBER 11, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Oncolytic immunotherapy biotech CG Oncology nabs $47M round for late-stage cancer push.Oncolytic immunotherapy biotech CG Oncology nabs $47M round for late-stage cancer push badams Fri, 12/11/2020 – … Continue reading (..)

Research 40

Research 40

BioTech 365

NOVEMBER 16, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: OSE details novel immuno-oncology strategy targeting ‘don’t eat me’ signaling in cancer.OSE details novel immuno-oncology strategy targeting ‘don’t eat me’ signaling in cancer arlene.weintraub (..)

Research 40

Research 40

BioTech 365

SEPTEMBER 10, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Opdivo trial offers new insights into how immuno-oncology drugs could be enhanced.Opdivo trial offers new insights into how immuno-oncology drugs could be enhanced aliu Thu, 09/10/2020 – … Continue reading →

Trials 40

Trials Drugs Research 40

BioTech 365

OCTOBER 7, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New immuno-oncology combo attacks glioblastoma in mice and paves path to human trials.New immuno-oncology combo attacks glioblastoma in mice and paves path to human trials arlene.weintraub Wed, … Continue reading → (..)

Trials 40

Trials Research 40

BioTech 365

MAY 4, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis loses 2nd oncology R&D exec as Hammerman leaves through the door left open by Engelman.Novartis loses 2nd oncology R&D exec as Hammerman leaves through the door … Continue reading →

Research 40

Research 40

BioTech 365

MAY 21, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ASCO: Boehringer, OSE offer promising glimpse of the immuno-oncology drug at the heart of their $1.4B

Drugs 40

Drugs Research 40

BioTech 365

OCTOBER 14, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After 15 years helping lead early cancer research at Genentech, Malek jumps ship to run Novartis’ NIBR oncology unit.After 15 years helping lead early cancer research at … Continue reading →

Research 40

Research 40

BioTech 365

JUNE 14, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race.GSK pays iTeos $625M upfront to join Merck, Roche and the rest … Continue reading →

Research 40

Research 40

BioTech 365

MARCH 18, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer ships out two cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO.Pfizer ships out two cancer ADCs alongside its tech platform to … Continue reading →

Research 40

Research 40

BioTech 365

JULY 29, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly bets $70M upfront but squeezes in a major $2B in biobucks for Kumquat and its small-molecule immuno-oncology work.Lilly bets $70M upfront but squeezes in a major … Continue reading →

Research 40

Research 40

Drug Discovery World

APRIL 12, 2024

News round-up for 8-12 April by DDW Digital Content Editor Diana Spencer. The cancer research news has been coming thick and fast from the American Association of Cancer Research (AACR) Annual Meeting in San Diego this week, so our Friday round-up focuses on drug discovery in oncology.

Drugs 52

Drugs Genetic Engineering Immune Response Engineer 52

STAT News

OCTOBER 10, 2022

is about to have not just one, but two, standalone publicly-traded oncology providers. Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public. The news comes about a year after another large oncology provider chain hit the stock market.

Doctors 105

Doctors Doctor Marketing 105

Drug Discovery World

APRIL 15, 2024

The cancer research news has been coming thick and fast from the American Association of Cancer Research (AACR) Annual Meeting in San Diego this week, so this round-up focuses on drug discovery in oncology. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Research 52

Research Drugs 52

Drug Channels

JUNE 27, 2023

on the Humira price war—and the role of cost-plus pharmacy pricing Fresh evidence that formulary exclusions hurt patients Disturbing oncology drug benefit management Plus, an entertaining explanation of why the U.S. Before you launch your July 4 festivities, Drug Channels offers some fireworks of our own: My $0.02

Drugs 82

Drugs Pharmacy 82

Drug Discovery World

JANUARY 15, 2024

The announcement follows the news that Merck agreed a deal with Inspirna for colorectal cancer drug ompenaclid (RGX-202). “At The post Merck continues to boost oncology pipeline through acquisitions appeared first on Drug Discovery World (DDW).

Clinical Development 105

Clinical Development Clinical Trials Clinical Trials Development 105

Drug Discovery World

APRIL 15, 2024

The cancer research news has been coming thick and fast from the American Association of Cancer Research (AACR) Annual Meeting in San Diego this week, so this round-up focuses on drug discovery in oncology. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Drugs 52

Drugs Research 52

World of DTC Marketing

SEPTEMBER 7, 2022

The biggest battle arena by far is oncology. According to JAMA , “in a cross-sectional study, between May 1, 2016, and May 31, 2021, there were 207 cancer drug approvals in oncology and malignant hematology. oncology therapeutics market has reached $71 billion. oncology therapeutics market has reached $71 billion.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

Drug Discovery World

OCTOBER 20, 2023

News round-up for 16-20 October by DDW Digital Content Editor Diana Spencer. To celebrate DDW’s first Turning Science into Business Summit on ‘Cancer research opportunities and advances’, the news round-up this week highlights the latest developments in oncology drug discovery.

Drugs 59

Drugs Research Medicine Marketing 59

STAT News

NOVEMBER 18, 2022

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  This time around, we note that Daiichi Sankyo hired Mark Rutstein as head, global oncology clinical development. Previously, he worked at Bristol Myers Squibb as vice president, oncology development. Don’t be shy.

Clinical Development 98

Clinical Development Development Drugs 98

Delveinsight

JULY 28, 2020

AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062. AstraZeneca has inked an oncology deal with Daiichi Sankyo to jointly develop and commercialize an antibody-drug conjugate DS-1062 (trastuzumab deruxtecan), worldwide except in Japan.

Gene Therapy 52

Gene Therapy Trials Gene Vaccination 52

BioSpace

SEPTEMBER 26, 2021

There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.

Clinical Trials 94

Clinical Trials Clinical Trials Trials 94

BioSpace

JUNE 3, 2021

With the 2021 American Society of Clinical Oncology Annual Meeting now in high gear, there is plenty of news. Here’s a look at just some of the most recent stories.

101

101

Camargo

MAY 10, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. head of the FDA’s Oncology Center of Excellence, and Julia Beaver, M.D., In the News: April 2021 Regulatory and Development Updates.

Development 185

Development Clinical Trials Clinical Trials Trials 185

XTalks

JULY 21, 2023

These members now have access to the advanced Iris platform, offering specialized mental health care tailored for oncology patients, 24×7 symptom management and essential nutritional support. That’s where Iris comes in,” said Andrew Norden, chief medical officer at OncoHealth, in the company’s news release. “We RELATED: care.ai

Nurses 98

Nurses Doctors Doctor Clinical Trials 98